Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:6 Issue:10 Number:31 ISSN#:2563-5476
ACE Report #9954
Ace Report Cover General Orthopaedics

OTA2017: Compliance similar between aspirin & enoxaparin in VTE prophylaxis after orthopaedic trauma

How to Cite

OrthoEvidence. OTA2017: Compliance similar between aspirin & enoxaparin in VTE prophylaxis after orthopaedic trauma. ACE Report. 2017;6(10):31. Available from: https://myorthoevidene.com/AceReport/Report/9954

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Inpatient Compliance with Venous Thromboembolism Prophylaxis in Orthopaedic Trauma: A Pragmatic Randomized Controlled Trial of Aspirin Versus Low Molecular Weight Heparin

Contributing Authors: GP Slobogean RV O'Toole T Manson NN O'Hara B Haac R van Besien D Stein

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


329 patients undergoing operative fixation of an extremity fracture were included in this trial to compare venous thromboembolism prophylaxis compliance between aspirin and enoxaparin. There was no difference in the percentage of patients that missed a dose (Asprin 41.2% and Enoxaparin 43.3%, p=0.7). Reasons for missed doses and refusal rates were simial between groups, with the exception of the i...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.